Alaunos Therapeutics, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Alaunos Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-12-31 was 0.00 shares.
- Alaunos Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-09-30 was 0.00 shares.
- Alaunos Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-06-30 was 0.00 shares.
- Alaunos Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-03-31 was 0.00 shares.
- Alaunos Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2025 was 0.00 shares.
- Alaunos Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2024 was 0.00 shares.
- Alaunos Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2023 was 0.00 shares, a 100.00% decline from fiscal 2022.
- Alaunos Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2022 was 1.75K shares, a 99.52% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2025-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | 0.00 shares 10-K · filed 2026-03-31 |
| 2025-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | |
| 2025-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | |
| 2025-03-31 | 0.00 shares 10-Q · filed 2025-05-15 | |
| 2024-12-31 | 0.00 shares 10-K · filed 2025-03-31 | |
| 2023-12-31 | 0.00 shares 10-K · filed 2025-03-31 | |
| 2022-12-31 | -24.50K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | 1.75K shares 10-K · filed 2024-04-01 |
| 2021-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-07 | 363.11K shares 10-K · filed 2023-03-07 |
| 2021-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | 678.53K shares derived: sum of 4 quarters · filed 2022-03-30 |
| 2021-06-30 | 10.67K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-13 | 693.28K shares derived: sum of 4 quarters · filed 2022-03-30 |
| 2021-03-31 | 352.44K shares 10-Q · filed 2021-05-06 | 688.44K shares derived: sum of 4 quarters · filed 2022-03-30 |
| 2020-12-31 | 315.42K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | 338.33K shares 10-K · filed 2022-03-30 |
| 2020-09-30 | 14.75K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | 121.52K shares derived: sum of 4 quarters · filed 2021-03-01 |
| 2020-06-30 | 5.83K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | 256.86K shares derived: sum of 4 quarters · filed 2021-03-01 |
| 2020-03-31 | 2.33K shares 10-Q · filed 2020-05-07 | |
| 2019-12-31 | 98.61K shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | 581.11K shares 10-K · filed 2021-03-01 |
| 2019-09-30 | 150.08K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | |
| 2018-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | 104.17K shares 10-K · filed 2021-03-01 |
| 2018-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | 204.17K shares derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-06-30 | 104.17K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | 204.17K shares derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-03-31 | 0.00 shares 10-Q · filed 2018-05-10 | 175.00K shares derived: sum of 4 quarters · filed 2020-03-02 |
| 2017-12-31 | 100.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | 180.00K shares 10-K · filed 2020-03-02 |
| 2017-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-06 | 145.83K shares derived: sum of 4 quarters · filed 2019-03-05 |
| 2017-06-30 | 75.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-31 | 145.83K shares derived: sum of 4 quarters · filed 2019-03-05 |
| 2017-03-31 | 5.00K shares 10-Q · filed 2017-05-01 | 146.16K shares derived: sum of 4 quarters · filed 2019-03-05 |
| 2016-12-31 | 65.83K shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-05 | 234.83K shares 10-K · filed 2019-03-05 |
| 2016-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | 480.00K shares derived: sum of 4 quarters · filed 2018-03-01 |
| 2016-06-30 | 75.33K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | 557.86K shares derived: sum of 4 quarters · filed 2018-03-01 |
| 2016-03-31 | 93.67K shares 10-Q · filed 2016-05-10 | 2.75M shares derived: sum of 4 quarters · filed 2018-03-01 |
| 2015-12-31 | 311.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | 3.25M shares 10-K · filed 2018-03-01 |
| 2015-09-30 | 77.86K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-02 | 2.97M shares derived: sum of 4 quarters · filed 2017-02-16 |
| 2015-06-30 | 2.27M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | 2.89M shares derived: sum of 4 quarters · filed 2017-02-16 |
| 2015-03-31 | 592.20K shares 10-Q · filed 2015-05-07 | 725.63K shares derived: sum of 4 quarters · filed 2017-02-16 |
| 2014-12-31 | 27.50K shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-16 | 613.14K shares 10-K · filed 2017-02-16 |
| 2014-09-30 | 2.60K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-30 | 585.64K shares derived: sum of 4 quarters · filed 2016-02-24 |
| 2014-06-30 | 103.33K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | 698.04K shares derived: sum of 4 quarters · filed 2016-02-24 |
| 2014-03-31 | 479.70K shares 10-Q · filed 2014-05-08 | 596.71K shares derived: sum of 4 quarters · filed 2016-02-24 |
| 2013-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-24 | 570.17K shares 10-K · filed 2016-02-24 |
| 2013-09-30 | 115.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-22 | 570.17K shares derived: sum of 4 quarters · filed 2015-02-26 |
| 2013-06-30 | 2.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-08 | 455.17K shares derived: sum of 4 quarters · filed 2015-02-26 |
| 2013-03-31 | 453.17K shares 10-Q · filed 2013-05-07 | |
| 2012-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-26 | 8.30K shares 10-K · filed 2015-02-26 |
| 2012-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q/A 6 month · filed 2012-11-08 | |
| 2011-12-31 | 479.67K shares 10-K · filed 2014-03-03 | |
| 2010-12-31 | 196.17K shares 10-K · filed 2013-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |